The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice.
Open accessAbstract
Experimental studies in vitro suggest that cytokines are impor- tant mediators in the pathogenesis of autoimmune insulin-de- pendent diabetes mellitus (IDDM).However, there is little evidence for the role ofcytokines in vivo, either in humans or in the spontaneous animal models of IDDM such as the NOD mouse or BB rat.To address this question, we used the model ofcyclo- phosphamide (CYP)-induced autoimmune diabetes in the NOD/Wehi mouse to examine for (a) the production of IFN-'y and IL-6 from isolated islets, and (b) the effect of anti IFN-'y or anti IL-6 monoclonal antibodies on the development of dia- betes.After cyclophosphamide, the majority of these mice de- velop of mononuclear cell infiltrate (insulitis) which by 10-14 d is associated with beta cell destruction.IFN-y activity at low levels (2.7±0.3U/ml) could be detected only in culture super- natants from islets isolated at day 7 post-cyclophosphamide.In contrast, IL-6 activity progressively increased from 457±44 U/ml at day 0 to 6,020±777 U/ml at day 10.Culture of islets with anti-CD3 monoclonal antibody resulted in a significant increase in IFN-'y activity from 41±7 U/ml at day 0 to 812±156 U/ml at day 10.Mice given either anti-IFN-y or anti- IL-6 antibody had a significantly reduced (P < 0.001) incidence of diabetes and especially with IFN-'y, decreased severity of insulitis.We conclude that IFN-y and IL-6 have essential roles in the pathogenesis of pancreatic islet beta cell destruction in this model.(J.Clin.Invest.1991.87:739-742.)Key words: anti-cytokine therapy * pancreatic islet * beta cell the production of IFN-'y and IL-6 from isolated islets, and (b) the effect of cytokine neutralization in vivo with anti-IFN-y and anti-IL-6 antibodies on the development of diabetes. MethodsMice.Female NOD/Wehi mice, aged 70-80 d, were used in all experi- ments.Although insulitis is present in virtually all mice, the incidence of diabetes in female NOD/Wehi mice in contrast to most strains of NOD mice, is < 5% at age 100 d (21).There are no differences between NOD/Wehi and the high-incidence strain, NOD/Lt on the basis of reciprocal skin grafting and allelic enzyme analysis (22).Monoclonal antibodies and cytokines.Monoclonal antibodies to IFN-y (RA-642; hybridoma cells obtained from the American Type Culture Collection, Rockville, MD) and IL-6 (6B4; hybridoma cells kindly provided by Dr. J. Van Snick, Brussels, Belgium) were obtained from ascites produced in CBA-Nu/Nu mice.After partial purification Interferon--y and Interleukin-6 in Autoimmune Diabetes 739
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eisenbarth (1986) · doi:10.1056/nejm198605223142106 · Cited by 1,659
Identification of a monoclonal antibody specific for a murine T3 polypeptide.
Leo, O., Foo, M., Sachs, D. H., Samelson, L. E., & Bluestone, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1374 · Cited by 1,593
Bottazzo, G. F., Dean, B. M., McNally, J. M., MacKay, E. H., Swift, P. G. F., & Gamble, D. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508083130604 · Cited by 932
An improved colorimetric assay for interleukin 2
Tada, H., Shiho, O., Kuroshima, K.-I., Koyama, M., & Tsukamoto, K. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90183-3 · Cited by 869
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Cytotoxicity of Human p I 7 Interleukin-1 for Pancreatic Islets of Langerhans
Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., & Svenson, M. (1986) · Science · doi:10.1126/science.3086977 · Cited by 529
Le, J., & Vilček, J. (1990) · Pathology Reviews • 1990 · doi:10.1007/978-1-4612-0485-5_7 · Cited by 474
Foulis, A. K., Liddle, C. N., Farquharson, M. A., Richmond, J. A., & Weir, R. S. (1986) · Diabetologia · doi:10.1007/bf00452061 · Cited by 469
Pujol–Borrell, R., Todd, I., Doshi, M., Bottazzo, G. F., Sutton, R., Gary, D., Adolf, G. R., & Feldmann, M. (1987) · Nature · doi:10.1038/326304a0 · Cited by 442
A Macrophage-Derived Factor Required by Plasmacytomas for Survival and Proliferation in Vitro
Nordan, R. P., & Potter, M. (1986) · Science · doi:10.1126/science.3726549 · Cited by 375
Cited by
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production
Ghayur, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter, A., Quintal, L., Sekut, L., Talanian, R., Paskind, M., et al. (1997) · Nature · doi:10.1038/386619a0 · Cited by 1,203
Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
Liblau, R. S., Singer, S. M., & McDevitt, H. O. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80068-9 · Cited by 1,105
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
IL-6 in autoimmune disease and chronic inflammatory proliferative disease
Ishihara, K., & Hirano, T. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00027-8 · Cited by 807
Interleukin 6 and its receptor: ten years later
Hirano, T. (1998) · International Reviews of Immunology · doi:10.3109/08830189809042997 · Cited by 788
T Helper Cell Subsets in Insulin-Dependent Diabetes
Katz, J. D., Benoist, C., & Mathis, D. (1995) · Science · doi:10.1126/science.7761837 · Cited by 593
Ogura, H., Murakami, M., Okuyama, Y., Tsuruoka, M., Kitabayashi, C., Kanamoto, M., Nishihara, M., Iwakura, Y., & Hirano, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.018 · Cited by 564
The role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. (1996) · Diabetologia · doi:10.1007/bf00400649 · Cited by 543
Hammond, K. J. L., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I., & Baxter, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1047 · Cited by 474
Bermudez, E. A., Rifai, N., Buring, J., Manson, J. E., & Ridker, P. M. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000029781.31325.66 · Cited by 469
Rabinovitch, A., & Suarez-Pinzon, W. L. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00492-9 · Cited by 466
Fowell, D., & Mason, D. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.627 · Cited by 436
Interferon-γ: Biology and Role in Pathogenesis
Billiau, A. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60428-9 · Cited by 433
Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M. K., & Adorini, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.817 · Cited by 423
Interferon-γ: A historical perspective
Billiau, A., & Matthys, P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.004 · Cited by 412
Cytokine regulation of T-cell function: potential for therapeutic intervention
Powrie, F., & Coffman, R. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90044-l · Cited by 408
Biology of human TH1 and TH2 cells
Romagnani, S. (1995) · Journal of Clinical Immunology · doi:10.1007/bf01543103 · Cited by 406
Divergent T-cell cytokine patterns in inflammatory arthritis.
Simon, A. K., Seipelt, E., & Sieper, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8562 · Cited by 377
Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivo
Powrie, F., Menon, S., & Coffman, R. L. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230926 · Cited by 328
Viral infections in type 1 diabetes mellitus — why the β cells?
Op de Beeck, A., & Eizirik, D. L. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.30 · Cited by 291
The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis
Padgett, L. E., Broniowska, K. A., Hansen, P. A., Corbett, J. A., & Tse, H. M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06826.x · Cited by 288
Type 1 diabetes as a relapsing–remitting disease?
von Herrath, M., Sanda, S., & Herold, K. (2007) · Nature Reviews Immunology · doi:10.1038/nri2192 · Cited by 270
Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction
Ehses, J. A., Ellingsgaard, H., Böni-Schnetzler, M., & Donath, M. Y. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903025879 · Cited by 97
Metadata
- Authors
- Campbell, I. L., Kay, T. W., Oxbrow, L., & Harrison, L. C.
- Venue
- Journal of Clinical Investigation
- Published
- 1991-02-01
- Volume
- 87
- Issue
- 2
- Pages
- 739-742
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2164924638
- Cited by
- 374
- References
- 27
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.